Maho Tsubota Selected Research

Antioxidants

1/2020	Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H2S/Cav3.2 Signaling in Mice.
2/2015	Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maho Tsubota Research Topics

Disease

32	Hyperalgesia 06/2023 - 01/2013
29	Pain (Aches) 01/2024 - 01/2013
11	Visceral Pain 01/2023 - 04/2014
10	Peripheral Nervous System Diseases (PNS Diseases) 01/2024 - 01/2016
9	Cystitis 01/2023 - 04/2014
8	Hypersensitivity (Allergy) 01/2023 - 01/2016
8	Inflammation (Inflammations) 01/2023 - 11/2013
6	Pancreatitis 01/2023 - 01/2013
5	Neoplasms (Cancer) 01/2023 - 01/2018
3	Neuralgia (Stump Neuralgia) 01/2023 - 01/2018
3	Intractable Pain 12/2022 - 01/2018
3	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2020 - 02/2015
3	Nociceptive Pain 01/2019 - 04/2014
3	Edema (Dropsy) 01/2018 - 04/2014
2	Multiple Myeloma 01/2021 - 01/2019
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2020 - 05/2020
2	Disseminated Intravascular Coagulation 01/2019 - 11/2013
2	Hyperthermia 01/2017 - 01/2017
1	Hyperglycemia 01/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Wounds and Injuries (Trauma) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Catalepsy 12/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 03/2022
1	Breast Neoplasms (Breast Cancer) 05/2021

Drug/Important Bio-Agent (IBA)

16	HMGB1 Protein (HMG1)IBA 01/2022 - 11/2013
12	ThrombomodulinIBA 05/2021 - 11/2013
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 04/2014
8	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2023 - 01/2018
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2016
6	CeruletideIBA 01/2023 - 01/2013
6	LyasesIBA 01/2023 - 02/2015
6	CystathionineIBA 01/2023 - 02/2015
6	Thrombin FDA Link 01/2021 - 04/2014
6	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2019 - 01/2014
5	Protein Isoforms (Isoforms)IBA 12/2022 - 02/2015
5	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 04/2014
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2015
4	ZincIBA 06/2023 - 02/2015
4	sodium sulfideIBA 01/2023 - 01/2016
4	Toll-Like Receptor 4IBA 01/2021 - 04/2014
4	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 11/2013
4	Neutralizing AntibodiesIBA 12/2020 - 11/2013
4	sodium bisulfide (NaHS)IBA 01/2019 - 01/2014
4	LipopolysaccharidesIBA 01/2018 - 04/2014
3	GasotransmittersIBA 01/2023 - 01/2014
3	EnzymesIBA 01/2023 - 02/2015
3	Calcium Channels (Calcium Channel)IBA 01/2023 - 01/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 01/2018
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 04/2014
3	Minocycline (Cyclops)FDA LinkGeneric 10/2018 - 01/2017
2	Chelating AgentsIBA 06/2023 - 01/2018
2	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 06/2023 - 01/2018
2	Cysteine (L-Cysteine)FDA Link 01/2023 - 02/2016
2	Pimozide (Orap)FDA Link 12/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
2	Butyrates (Butyrate)IBA 02/2021 - 11/2020
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
2	Bortezomib (Velcade)FDA Link 01/2021 - 01/2019
2	Dihydrotachysterol (AT 10)IBA 01/2021 - 01/2016
2	Substance PIBA 06/2020 - 01/2018
2	Calcineurin InhibitorsIBA 05/2020 - 01/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 01/2017
2	Capsaicin (Zostrix)FDA Link 05/2020 - 01/2014
2	CalcineurinIBA 05/2020 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020 - 01/2017
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 10/2018
2	AntioxidantsIBA 01/2020 - 02/2015
2	NNC 55-0396IBA 06/2019 - 02/2015
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 11/2013
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019 - 02/2015
2	prolinedithiocarbamate (PDTC)IBA 10/2018 - 01/2018
2	Clodronic Acid (Clodronate)IBA 10/2018 - 12/2017
2	ethyl pyruvateIBA 10/2018 - 12/2017
2	ProstaglandinsIBA 01/2018 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 01/2013
2	Alanine (L-Alanine)FDA Link 01/2018 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 01/2016 - 11/2013
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2024
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2024
1	Perindopril FDA LinkGeneric 01/2024
1	NAD (NADH)IBA 01/2024
1	Telmisartan (Micardis)FDA Link 01/2024
1	AngiotensinsIBA 01/2024
1	Angiotensin Receptor AntagonistsIBA 01/2024
1	3-(trihydroxygermyl)propanoic acidIBA 01/2023
1	GermaniumIBA 01/2023
1	Morphine (MS Contin)FDA LinkGeneric 01/2023
1	Sulfides (Thioethers)IBA 01/2023
1	SulfurIBA 01/2023
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2022
1	Estrogens (Estrogen)FDA Link 05/2021
1	Bepridil (Vascor)FDA Link 01/2021
1	sym-trinitrobenzeneIBA 01/2021
1	Dopamine D2 Receptor AntagonistsIBA 01/2021
1	Sulfonic AcidsIBA 01/2021

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 03/2022 - 01/2016
2	Ligation 01/2018 - 01/2018
1	Therapeutics 05/2021